BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28190297)

  • 1. Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53-dependent manner.
    Zhang B; Shi X; Xu G; Kang W; Zhang W; Zhang S; Cao Y; Qian L; Zhan P; Yan H; To KF; Wang L; Zou X
    J Cell Mol Med; 2017 Jul; 21(7):1329-1341. PubMed ID: 28190297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
    Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
    Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prostaglandin reductase 1 (PTGR1) on gastric carcinoma using lentivirus-mediated system.
    Yang S; Luo F; Wang J; Mao X; Chen Z; Wang Z; Guo F
    Int J Clin Exp Pathol; 2015; 8(11):14493-9. PubMed ID: 26823768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
    Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
    Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.
    Shi J; Qu Y; Li X; Sui F; Yao D; Yang Q; Shi B; Ji M; Hou P
    Cell Death Dis; 2016 Oct; 7(10):e2442. PubMed ID: 27787520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer.
    Kobayashi T; Ishida J; Shimizu Y; Kawakami H; Suda G; Muranaka T; Komatsu Y; Asaka M; Sakamoto N
    Tumour Biol; 2017 Mar; 39(3):1010428317694547. PubMed ID: 28347247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Expression of RPA3 Is Involved in Gastric Cancer Tumorigenesis and Associated with Poor Patient Survival.
    Dai Z; Wang S; Zhang W; Yang Y
    Dig Dis Sci; 2017 Sep; 62(9):2369-2375. PubMed ID: 28766245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
    Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
    J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
    Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
    Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of EPCR inhibits the proliferation and migration of human gastric cancer cells via the ERK1/2 pathway in a PAR-1-dependent manner.
    Wang Q; Yang H; Zhuo Q; Xu Y; Zhang P
    Oncol Rep; 2018 Apr; 39(4):1843-1852. PubMed ID: 29484413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
    Habib R; Akhtar J; Taqi M; Yu C; Zhang C
    Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
    Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
    Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
    Peng W; Wu G; Fan H; Wu J; Feng J
    Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PRC1 indicates a poor prognosis in ovarian cancer.
    Bu H; Li Y; Jin C; Yu H; Wang X; Chen J; Wang Y; Ma Y; Zhang Y; Kong B
    Int J Oncol; 2020 Mar; 56(3):685-696. PubMed ID: 31922238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
    Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
    Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PABPC1 exerts carcinogenesis in gastric carcinoma by targeting miR-34c.
    Zhu J; Ding H; Wang X; Lu Q
    Int J Clin Exp Pathol; 2015; 8(4):3794-802. PubMed ID: 26097561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.